Erwin Tomasich
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 8
- Cancer-related gene regulation 4
- RNA modifications and cancer 3
- Oncology 16
- Cancer Immunotherapy and Biomarkers 10
- PARP inhibition in cancer therapy 3
- Co-authors
- Gerwin Heller (21 shared papers)Maximilian Marhold (10 shared papers)Michael Krainer (9 shared papers)Peter Horak (6 shared papers)Reinhard Horvat (3 shared papers)Leonhard Müllauer (7 shared papers)Sabine Zöchbauer‐Müller (4 shared papers)Barbara Ziegler (4 shared papers)
In The Last Decade
Erwin Tomasich
29 papers receiving 544 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 187
- Oncology 179
- Molecular Biology 336
- Pulmonary and Respiratory Medicine 120
- Immunology 72
Countries citing papers authored by Erwin Tomasich
This map shows the geographic impact of Erwin Tomasich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Tomasich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Tomasich more than expected).
Fields of papers citing papers by Erwin Tomasich
This network shows the impact of papers produced by Erwin Tomasich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Tomasich. The network helps show where Erwin Tomasich may publish in the future.
Co-authors
The 25 scholars most cited alongside Erwin Tomasich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 106 | |
| 2 | 2014 | 72 | |
| 3 | 2014 | 47 | |
| 4 | 2015 | 41 | |
| 5 | 2020 | 39 | |
| 6 | 2021 | 34 | |
| 7 | 2018 | 27 | |
| 8 | 2019 | 27 | |
| 9 | 2015 | 24 | |
| 10 | 2014 | 23 | |
| 11 | 2022 | 19 | |
| 12 | 2023 | 14 | |
| 13 | 2019 | 12 | |
| 14 | 2024 | 11 | |
| 15 | 2020 | 10 | |
| 16 | 2022 | 10 | |
| 17 | 2022 | 8 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 3 |
About Erwin Tomasich
Erwin Tomasich is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 31 papers that have together received 547 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Epigenetics and DNA Methylation (8 papers), Brain Metastases and Treatment (4 papers), Cancer-related gene regulation (4 papers), PARP inhibition in cancer therapy (3 papers), Immunotherapy and Immune Responses (3 papers), RNA modifications and cancer (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (187 citations), Oncology (179 citations), Molecular Biology (336 citations), Pulmonary and Respiratory Medicine (120 citations) and Immunology (72 citations). Erwin Tomasich has collaborated with scholars based in Austria, Germany and Hungary. Frequent co-authors include Gerwin Heller, Maximilian Marhold, Michael Krainer, Peter Horak, Reinhard Horvat, Leonhard Müllauer, Sabine Zöchbauer‐Müller, Barbara Ziegler, Christoph Minichsdorfer and Andreas Spittler. Their work appears in journals such as Clinical Cancer Research, Scientific Reports, Translational research, Annals of Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.